NeoGenomics Stock In A Range-Bound Matrix, Weakness Likely Until 2026
1. NEO is in Phase 18, consolidating for over 850 days. 2. Signs of a breakout remain weak until at least August 2026. 3. Historical trends show risk of declining to $18 price level. 4. Weak Guna Triads indicate lack of bullish momentum. 5. Investors should hold off on new positions in NEO.